Responses
Palliative care
Protocol
Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study)
Compose a Response to This Article
Other responses
No responses have been published for this article.